A pediatric protocol for management of extravasation injuries.
The administration of bioactive agents through IV can lead to serious complications, including partial-or full-thickness skin loss, infection, nerve and tendon damage, or loss of limb. Children's Hospital of The King's Daughters (CHKD) implemented a protocol to uniformity identify and treat infiltrates in order to avoid these serious potential complications.
Flemmer
L
L
Chan
J S
JS
D000931:Antidotes / Q000627:therapeutic use*; D002985:Clinical Protocols; D005119:Extravasation of Diagnostic and Therapeutic Materials / Q000451:nursing*; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000627:therapeutic use; D007231:Infant, Newborn; D007234:Infant, Premature; D005996:Nitroglycerin / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D012871:Skin Diseases / Q000139:chemically induced / Q000451:nursing
D000931:Antidotes; D006821:Hyaluronoglucosaminidase; D005996:Nitroglycerin; D010646:Phentolamine